Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $642,902 (100.0% shares, 0.0% debt)

Holdings (42)

APLS APELLIS PHARMACEUTICALS INC 13.5%
Value ($000) $86,721 Shares 3,006,980 Est. Cost $47.09 Unrealized -21.4%
VERONA PHARMA PLC 8.2%
Value ($000) $52,799 Shares 1,835,200 Est. Cost $17.59 Unrealized
GPCR STRUCTURE THERAPEUTICS INC 8.2%
Value ($000) $52,580 Shares 1,198,000 Est. Cost $40.29 Unrealized
DNTH DIANTHUS THERAPEUTICS INC 7.4%
Value ($000) $47,824 Shares 1,746,667 Est. Cost $19.26 Unrealized +44.6%
AVBP ARRIVENT BIOPHARMA INC 7.2%
Value ($000) $46,445 Shares 1,976,387 Est. Cost $20.39 Unrealized +11.3%
CNTA CENTESSA PHARMACEUTICALS PLC 5.0%
Value ($000) $32,173 Shares 2,012,052 Est. Cost $7.34 Unrealized
INSM INSMED INC 5.0%
Value ($000) $31,888 Shares 436,820 Est. Cost $21.76 Unrealized +239.2%
NUVB NUVATION BIO INC 4.3%
Value ($000) $27,873 Shares 12,171,513 Est. Cost $2.99 Unrealized +1.9%
CRBP CORBUS PHARMACEUTICALS HLDGS 3.6%
Value ($000) $23,002 Shares 1,115,000 Est. Cost $40.87 Unrealized +25.2%
OCUL OCULAR THERAPEUTIX INC 3.3%
Value ($000) $21,098 Shares 2,425,000 Est. Cost $7.10 Unrealized +16.1%
VRDN VIRIDIAN THERAPEUTICS INC 3.1%
Value ($000) $19,793 Shares 870,000 Est. Cost $22.43 Unrealized -27.1%
CATX PERSPECTIVE THERAPEUTICS INC 3.0%
Value ($000) $18,987 Shares 1,422,224 Est. Cost $14.46 Unrealized -8.0%
INSM INSMED INC 2.8%
Value ($000) $18,250 Shares 250,000 Est. Cost $21.76 Unrealized +239.2%
MIND MEDICINE MINDMED INC 2.7%
Value ($000) $17,172 Shares 3,018,000 Est. Cost $8.34 Unrealized
COGT COGENT BIOSCIENCES INC 2.2%
Value ($000) $14,094 Shares 1,305,000 Est. Cost $9.74 Unrealized 0.0%
BBIO BRIDGEBIO PHARMA INC 2.2%
Value ($000) $14,054 Shares 552,000 Est. Cost $30.51 Unrealized -13.9%
PHVS PHARVARIS N V 1.8%
Value ($000) $11,491 Shares 620,470 Est. Cost $18.27 Unrealized 0.0%
DYN DYNE THERAPEUTICS INC 1.5%
Value ($000) $9,437 Shares 262,726 Est. Cost $16.21 Unrealized +145.5%
TSHA TAYSHA GENE THERAPIES INC 1.4%
Value ($000) $9,190 Shares 4,572,222 Est. Cost $2.36 Unrealized -7.1%
GOSS GOSSAMER BIO INC 1.4%
Value ($000) $9,063 Shares 9,187,883 Est. Cost $2.93 Unrealized -67.1%
ALLOVIR INC 1.4%
Value ($000) $9,057 Shares 11,202,000 Est. Cost $0.75 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 1.4%
Value ($000) $8,737 Shares 1,093,503 Est. Cost $24.76 Unrealized -64.5%
PRAX PRAXIS PRECISION MEDICINES I 1.2%
Value ($000) $7,480 Shares 130,000 Est. Cost $44.86 Unrealized +20.4%
MLYS MINERALYS THERAPEUTICS INC 1.1%
Value ($000) $7,266 Shares 600,000 Est. Cost $12.37 Unrealized -2.1%
REGULUS THERAPEUTICS INC 1.0%
Value ($000) $6,694 Shares 4,263,701 Est. Cost $1.78 Unrealized
VTYX VENTYX BIOSCIENCES INC 0.8%
Value ($000) $5,213 Shares 2,391,114 Est. Cost $4.42 Unrealized -47.9%
TNYA TENAYA THERAPEUTICS INC 0.8%
Value ($000) $4,972 Shares 2,576,200 Est. Cost $4.78 Unrealized -41.0%
HELP CYBIN INC 0.7%
Value ($000) $4,353 Shares 489,596 Est. Cost $9.89 Unrealized 0.0%
RENEO PHARMACEUTICALS INC 0.6%
Value ($000) $3,825 Shares 2,250,000 Est. Cost $6.46 Unrealized
UNICYCIVE THERAPEUTICS INC 0.5%
Value ($000) $3,491 Shares 8,559,000 Est. Cost $0.41 Unrealized
PEPG PEPGEN INC 0.5%
Value ($000) $3,216 Shares 376,117 Est. Cost $11.81 Unrealized +0.2%
BBOT HELIX ACQUISITION CORP II 0.4%
Value ($000) $2,612 Shares 250,000 Est. Cost $10.35 Unrealized +0.1%
BDTX BLACK DIAMOND THERAPEUTICS I 0.4%
Value ($000) $2,584 Shares 594,000 Est. Cost $5.44 Unrealized 0.0%
ANNX ANNEXON INC 0.4%
Value ($000) $2,368 Shares 400,000 Est. Cost $4.77 Unrealized +24.3%
MERSANA THERAPEUTICS INC 0.3%
Value ($000) $1,875 Shares 992,000 Est. Cost $4.48 Unrealized
IPSC CENTURY THERAPEUTICS INC 0.2%
Value ($000) $1,140 Shares 666,825 Est. Cost $3.59 Unrealized -45.5%
AEROVATE THERAPEUTICS INC 0.2%
Value ($000) $973 Shares 465,440 Est. Cost $25.63 Unrealized
NUVATION BIO INC 0.1%
Value ($000) $715 Shares 312,336 Est. Cost $2.29 Unrealized
AUTL AUTOLUS THERAPEUTICS PLC 0.1%
Value ($000) $639 Shares 176,000 Est. Cost $6.38 Unrealized
NGNE NEUROGENE INC 0.1%
Value ($000) $629 Shares 15,000 Est. Cost $38.78 Unrealized 0.0%
RAPT THERAPEUTICS INC 0.1%
Value ($000) $587 Shares 292,000 Est. Cost $24.85 Unrealized
NKTX NKARTA INC 0.1%
Value ($000) $542 Shares 120,000 Est. Cost $10.40 Unrealized -45.4%